| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 10 | 2022 | 1515 | 1.740 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 3 | 2023 | 85 | 1.640 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 3 | 2018 | 66 | 1.530 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2023 | 490 | 1.480 |
Why?
|
| RNA Helicases | 2 | 2022 | 63 | 1.470 |
Why?
|
| Receptors, Androgen | 4 | 2023 | 409 | 1.300 |
Why?
|
| Inflammation | 5 | 2022 | 1402 | 1.130 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2018 | 137 | 1.060 |
Why?
|
| Neoplasms | 5 | 2023 | 2758 | 1.020 |
Why?
|
| Prostate | 6 | 2014 | 421 | 0.990 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2023 | 206 | 0.990 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2023 | 18 | 0.880 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2023 | 340 | 0.870 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2022 | 10 | 0.830 |
Why?
|
| Guanidines | 1 | 2022 | 25 | 0.820 |
Why?
|
| GATA2 Transcription Factor | 1 | 2022 | 45 | 0.820 |
Why?
|
| Keto Acids | 1 | 2022 | 55 | 0.810 |
Why?
|
| Transaminases | 1 | 2022 | 32 | 0.810 |
Why?
|
| Stromal Cells | 6 | 2014 | 294 | 0.790 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 21 | 0.770 |
Why?
|
| Co-Repressor Proteins | 1 | 2021 | 37 | 0.760 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 290 | 0.720 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2023 | 1870 | 0.710 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 353 | 0.680 |
Why?
|
| Transforming Growth Factor beta | 4 | 2014 | 455 | 0.680 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 315 | 0.640 |
Why?
|
| Gene Transfer Techniques | 2 | 2018 | 357 | 0.640 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 223 | 0.640 |
Why?
|
| Alpharetrovirus | 1 | 2018 | 5 | 0.600 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 126 | 0.580 |
Why?
|
| Cell Line, Tumor | 9 | 2023 | 3273 | 0.550 |
Why?
|
| Retroviridae | 1 | 2017 | 194 | 0.550 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2014 | 107 | 0.520 |
Why?
|
| Mice | 18 | 2022 | 17496 | 0.520 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 1676 | 0.450 |
Why?
|
| Animals | 21 | 2022 | 33761 | 0.420 |
Why?
|
| Mice, SCID | 2 | 2022 | 571 | 0.340 |
Why?
|
| Signal Transduction | 5 | 2023 | 4493 | 0.340 |
Why?
|
| Androgens | 3 | 2023 | 256 | 0.330 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 2476 | 0.320 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2017 | 617 | 0.310 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2022 | 269 | 0.290 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2007 | 54 | 0.290 |
Why?
|
| Proteins | 4 | 2014 | 1039 | 0.270 |
Why?
|
| Immediate-Early Proteins | 1 | 2005 | 58 | 0.250 |
Why?
|
| Androgen Antagonists | 2 | 2023 | 114 | 0.250 |
Why?
|
| Carcinoma | 1 | 2007 | 278 | 0.240 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 281 | 0.230 |
Why?
|
| Humans | 21 | 2023 | 123213 | 0.210 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 650 | 0.210 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2022 | 21 | 0.200 |
Why?
|
| Micrococcal Nuclease | 1 | 2001 | 7 | 0.190 |
Why?
|
| Staphylococcus | 1 | 2001 | 69 | 0.190 |
Why?
|
| Mice, Knockout | 3 | 2021 | 3718 | 0.190 |
Why?
|
| Protein Isoforms | 1 | 2022 | 408 | 0.190 |
Why?
|
| Cell Line | 4 | 2021 | 2773 | 0.190 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2021 | 137 | 0.190 |
Why?
|
| Protein Conformation | 3 | 2003 | 834 | 0.180 |
Why?
|
| Tumor Cells, Cultured | 3 | 2014 | 1063 | 0.180 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 105 | 0.180 |
Why?
|
| Th1 Cells | 1 | 2021 | 152 | 0.170 |
Why?
|
| Th17 Cells | 1 | 2021 | 90 | 0.170 |
Why?
|
| Mass Spectrometry | 1 | 2001 | 326 | 0.170 |
Why?
|
| Kupffer Cells | 1 | 2020 | 19 | 0.170 |
Why?
|
| Cell Survival | 1 | 2022 | 806 | 0.170 |
Why?
|
| Male | 15 | 2023 | 60117 | 0.170 |
Why?
|
| Mice, Nude | 5 | 2014 | 695 | 0.170 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2022 | 877 | 0.170 |
Why?
|
| Receptors, Calcitriol | 1 | 2020 | 71 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 4348 | 0.170 |
Why?
|
| Hepatitis | 1 | 2020 | 59 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 667 | 0.170 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 477 | 0.160 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 428 | 0.160 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 216 | 0.160 |
Why?
|
| Serine Endopeptidases | 2 | 2014 | 175 | 0.160 |
Why?
|
| DNA Damage | 1 | 2021 | 507 | 0.150 |
Why?
|
| HEK293 Cells | 1 | 2021 | 740 | 0.150 |
Why?
|
| DNA Repair | 1 | 2021 | 581 | 0.150 |
Why?
|
| Neovascularization, Pathologic | 4 | 2007 | 240 | 0.150 |
Why?
|
| Luciferases | 1 | 1997 | 137 | 0.140 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 4276 | 0.140 |
Why?
|
| Mitochondria | 1 | 2022 | 677 | 0.140 |
Why?
|
| Transplantation, Heterologous | 3 | 2007 | 253 | 0.140 |
Why?
|
| Calcium | 1 | 2022 | 1096 | 0.140 |
Why?
|
| Oncogenes | 1 | 2018 | 168 | 0.140 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2014 | 126 | 0.140 |
Why?
|
| Ribosomes | 1 | 1997 | 143 | 0.140 |
Why?
|
| Cysteine Endopeptidases | 1 | 2017 | 114 | 0.140 |
Why?
|
| Endopeptidases | 1 | 2017 | 115 | 0.140 |
Why?
|
| Immunotherapy | 1 | 2021 | 653 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 215 | 0.130 |
Why?
|
| Pteridines | 1 | 2014 | 8 | 0.120 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2014 | 10 | 0.120 |
Why?
|
| Phenylthiohydantoin | 1 | 2014 | 12 | 0.120 |
Why?
|
| Sequence Deletion | 1 | 2017 | 527 | 0.120 |
Why?
|
| Kallikreins | 1 | 2014 | 26 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2020 | 638 | 0.120 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 387 | 0.120 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2014 | 33 | 0.120 |
Why?
|
| Myofibroblasts | 1 | 2014 | 75 | 0.120 |
Why?
|
| Benzamides | 1 | 2014 | 106 | 0.120 |
Why?
|
| Disease Progression | 2 | 2013 | 2026 | 0.110 |
Why?
|
| Microarray Analysis | 1 | 2014 | 231 | 0.110 |
Why?
|
| Nitriles | 1 | 2014 | 146 | 0.110 |
Why?
|
| Prostate-Specific Antigen | 1 | 2014 | 247 | 0.110 |
Why?
|
| beta Catenin | 1 | 2015 | 205 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 2390 | 0.110 |
Why?
|
| Mice, Inbred ICR | 1 | 2013 | 147 | 0.110 |
Why?
|
| Interleukin-6 | 1 | 2014 | 393 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 512 | 0.100 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 473 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2014 | 1101 | 0.100 |
Why?
|
| Carcinogenesis | 1 | 2015 | 328 | 0.100 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2015 | 383 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 1292 | 0.100 |
Why?
|
| Apoptosis | 2 | 2017 | 1781 | 0.100 |
Why?
|
| Ganglia | 1 | 2010 | 20 | 0.090 |
Why?
|
| Wound Healing | 1 | 2014 | 452 | 0.090 |
Why?
|
| Macrophages | 1 | 2014 | 605 | 0.090 |
Why?
|
| RNA, Messenger | 2 | 2014 | 2815 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2013 | 1472 | 0.080 |
Why?
|
| 3T3 Cells | 2 | 2005 | 129 | 0.080 |
Why?
|
| Female | 3 | 2022 | 65516 | 0.080 |
Why?
|
| Protein Biosynthesis | 2 | 2003 | 666 | 0.070 |
Why?
|
| Liver | 1 | 2015 | 1734 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2014 | 2306 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 1582 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 133 | 0.070 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 530 | 0.070 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2005 | 19 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2007 | 473 | 0.060 |
Why?
|
| HIV-1 | 1 | 2007 | 465 | 0.060 |
Why?
|
| Aging | 1 | 2010 | 1174 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 1 | 2003 | 64 | 0.050 |
Why?
|
| Muramidase | 1 | 2003 | 92 | 0.050 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2023 | 19 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2023 | 172 | 0.050 |
Why?
|
| Binding Sites | 2 | 2003 | 1291 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2003 | 1070 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2001 | 59 | 0.050 |
Why?
|
| Radioimmunotherapy | 1 | 2021 | 2 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2001 | 155 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2001 | 239 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 1584 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 1687 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2020 | 62 | 0.040 |
Why?
|
| Ligands | 1 | 2001 | 533 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2021 | 171 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 752 | 0.040 |
Why?
|
| Vitamin D | 1 | 2020 | 159 | 0.040 |
Why?
|
| Cell Division | 2 | 2014 | 780 | 0.040 |
Why?
|
| Coleoptera | 1 | 1997 | 13 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 1010 | 0.040 |
Why?
|
| Protein Binding | 1 | 2001 | 1740 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1997 | 316 | 0.040 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 198 | 0.030 |
Why?
|
| Protein Stability | 1 | 2017 | 165 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2017 | 312 | 0.030 |
Why?
|
| Cell Movement | 2 | 2014 | 831 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 1997 | 389 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 892 | 0.030 |
Why?
|
| Osteopontin | 1 | 2014 | 49 | 0.030 |
Why?
|
| Fibronectins | 1 | 2014 | 105 | 0.030 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2014 | 57 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 1386 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 233 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2014 | 137 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2014 | 319 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2015 | 161 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 258 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2014 | 340 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 664 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 1997 | 1695 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1997 | 977 | 0.020 |
Why?
|
| Organoids | 1 | 2014 | 277 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 4227 | 0.020 |
Why?
|
| Time Factors | 1 | 2001 | 6217 | 0.020 |
Why?
|
| Genetic Variation | 1 | 1997 | 1480 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 715 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 669 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 661 | 0.020 |
Why?
|
| Obesity | 1 | 2020 | 2227 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1682 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 993 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2014 | 1907 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2007 | 237 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2007 | 193 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 935 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 3091 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2021 | 12134 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 1308 | 0.010 |
Why?
|
| CHO Cells | 1 | 2003 | 156 | 0.010 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2003 | 26 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2003 | 79 | 0.010 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2003 | 50 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 273 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 409 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2003 | 369 | 0.010 |
Why?
|
| Chickens | 1 | 2003 | 636 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2003 | 169 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2003 | 357 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2003 | 239 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2002 | 149 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 3045 | 0.010 |
Why?
|
| Antibodies | 1 | 2002 | 369 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 5773 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 8886 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2002 | 747 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 3868 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 29091 | 0.010 |
Why?
|